Ultragenyx Pharmaceutical
RARE
RARE
231 hedge funds and large institutions have $2.81B invested in Ultragenyx Pharmaceutical in 2022 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 94 increasing their positions, 60 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.34% more ownership
Funds ownership: 96.57% → 96.91% (+0.34%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less capital invested
Capital invested by funds: $4.03B → $2.81B (-$1.22B)
Holders
231
Holding in Top 10
1
Calls
$17.4M
Puts
$14.4M
Top Buyers
| 1 | +$67.6M | |
| 2 | +$40.9M | |
| 3 | +$23.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$14.2M |
| 5 |
BlackRock
New York
|
+$13.7M |
Top Sellers
| 1 | -$249M | |
| 2 | -$86.3M | |
| 3 | -$34.6M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$21.7M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.4M |